by | Sep 26, 2023 | Publications
J Clin Virol. 2023 Sep 20;168:105598. doi: 10.1016/j.jcv.2023.105598. Online ahead of print. ABSTRACT BACKGROUND: Human T-cell leukemia virus type 1 (HTLV-1) is a blood-borne virus, and mandatory testing of donated blood for HTLV-1 antibodies has been adopted by...
by HTLV | Sep 24, 2023 | Publications
Abstract HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic,progressive, neuroinflammatory demyelinating condition of the spinal cord. Wehave previously shown that aberrant expression and activity of immune check-point (ICP) molecules...
by | Sep 22, 2023 | Publications
Infect Dis Rep. 2023 Aug 31;15(5):478-493. doi: 10.3390/idr15050048. ABSTRACT To achieve the objective of this study, we conducted a narrative review on physical therapeutic modalities applied to prevent functional losses associated with human T-lymphotropic virus 1...
by | Sep 20, 2023 | Publications
Epidemiol Serv Saude. 2023 Sep 18;32(2):e2023565. doi: 10.1590/S2237-96222023000200025. NO ABSTRACT PMID:37729266 | DOI:10.1590/S2237-96222023000200025
by | Sep 18, 2023 | Publications
Front Genet. 2023 Aug 31;14:1250545. doi: 10.3389/fgene.2023.1250545. eCollection 2023. ABSTRACT Introduction: Intercellular adhesion molecule 1 (ICAM-1) is a critical molecule responsible for interactions between cells. Previous studies have suggested that ICAM-1...
by | Sep 15, 2023 | Publications
Front Med (Lausanne). 2023 Aug 30;10:1239706. doi: 10.3389/fmed.2023.1239706. eCollection 2023. ABSTRACT Human T-lymphotropic virus 1 (HTLV-1) infected individuals remain as asymptomatic carriers (ACs) or can develop the chronic neurological disorder HTLV-1-associated...
